ARCHIVES

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

ACS Asks Higher NCI Authorization

March 24, 1978

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

CPSC Relies On NCI Findings For New Policy

July 21, 1978

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011